Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Myriad Genetics Incorporated published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 22
» View herald-mail.com items only
    May 21, 2013 |Column| Los Angeles Times

  1. Angelina Jolie's courageous act will save women's lives

    Four days after her April 27 breast reconstruction, the third and final surgery aimed at sparing her an early death from breast cancer, Angelina Jolie was in good spirits at home.
    Four days after her April 27 breast reconstruction, the third and final surgery aimed at sparing her an early death from breast cancer, Angelina Jolie was in good spirits at home. Upon paying a house call, her surgeon, Dr. Kristi Funk of the Pink...

    Tags: Medical Specialization, American Civil Liberties Union, U.S. Supreme Court, Medical Research, Breast Reconstruction

    2. May 14, 2013 |Story| Los Angeles Times

  2. Angelina Jolie mastectomy: A closer look at DNA, breast cancer risk

    By opting for surgery to remove her breasts while they were still healthy, Angelina Jolie joined a growing number of women who have used genetic testing to take control of their health.
    By opting for surgery to remove her breasts while they were still healthy, Angelina Jolie joined a growing number of women who have used genetic testing to take control of their health. Here are answers to some common questions about how DNA...

    Tags: Biotechnology Industry, New Haven (New Haven, Connecticut), St. John's Health Center, Hormone Replacement Therapy, Mastectomy

    3. May 14, 2013 |Story| AP Member Choice Limited

  3. Angelina Jolie's double mastectomy: Q&A

    AP Medical Writer
    Oscar-winning actress Angelina Jolie disclosed Tuesday that she had a preventive mastectomy after learning she had a gene mutation that significantly raised her risk of breast cancer. A look at the procedure: Q: What kind of surgery did Jolie have? A:...

    Tags: Medical Specialization, Health and Medical Professionals, United Kingdom, Science and Technology, Medical Procedures and Tests

    4. May 14, 2013 |Story| Los Angeles Times

  4. Angelina Jolie and the fate of breast cancer genes

    Angelina Jolie&rsquo;s <a href="http://www.nytimes.com/2013/05/14/opinion/my-medical-choice.html?_r=0">Op-Ed</a> in the New York Times about getting a double mastectomy after learning that she was at risk of getting breast cancer <a>struck a chord</a> with fellow celebs as well as with Los Angeles Times staffers <a href="http://www.latimes.com/news/science/sciencenow/la-sci-sn-brca-20130514,0,5718909.story">Anna Gorman</a> and <a href="http://www.latimes.com/news/opinion/opinion-la/la-ol-angelina-jolie-cancer-family-tree-20130514,0,1239083.story">Paul Whitefield</a>, who wrote about their own experiences Tuesday.&nbsp;
    Angelina Jolie’s Op-Ed in the New York Times about getting a double mastectomy after learning that she was at risk of getting breast cancer struck a chord with fellow celebs as well as with Los Angeles Times staffers Anna Gorman and Paul Whitefield,...

    Tags: Medical Specialization, American Civil Liberties Union, Biotechnology Industry, U.S. Supreme Court, Medical Research

    5. Apr 28, 2013 |Story| Baltimore Sun

  5. The red herring of human gene patents

    The greatest dangers to liberty lurk in the insidious encroachment by men of zeal, well meaning but without understanding. &mdash; Louis D. Brandeis
    The greatest dangers to liberty lurk in the insidious encroachment by men of zeal, well meaning but without understanding. — Louis D. Brandeis Just a few words and little thought separate yet another stronghold of the American economy from ruin....

    Tags: Medical Specialization, Johns Hopkins University, Biotechnology Industry, Herring, Medical Research

    6. Apr 15, 2013 |Story| Los Angeles Times

  6. Can a company patent your DNA? Supreme Court hears BRCA gene case

    Can a private company own rights to your DNA?
    Can a private company own rights to your DNA? The nine justices of the Supreme Court will consider that question Monday as lawyers for Myriad Genetics make their best case that the company should be able to keep its patent on two genes known to...

    Tags: Medical Specialization, American Civil Liberties Union, Biotechnology Industry, Business Enterprises, University of Utah

    7. Apr 16, 2013 |Column| Orlando Sentinel

  7. Deep in the reeds on genes

    WASHINGTON -- Mitt Romney had it wrong. Corporations aren't people -- corporations own people. The Supreme Court on Monday took up the unusual question of whether corporations control our genetic material -- specifically, whether a Utah-based company...

    Tags: Economy, Business and Finance, Clarence Thomas, Baseball, John G. Roberts, Jr., Companies and Corporations

    8. Apr 15, 2013 |Story| Los Angeles Times

  8. Supreme Court critical of patents on human genes

    WASHINGTON &mdash; The Supreme Court justices said Monday they were highly skeptical of the idea that a company or a scientist can hold a patent on human genes and prevent others from testing or using them.
    WASHINGTON — The Supreme Court justices said Monday they were highly skeptical of the idea that a company or a scientist can hold a patent on human genes and prevent others from testing or using them. “What about the first person who found a...

    Tags: Medical Specialization, American Civil Liberties Union, Biotechnology Industry, Justice System, Medical Research

    9. Apr 16, 2013 |Story| Los Angeles Times

  9. Supreme Court seems opposed to granting patents on human genes

    WASHINGTON &mdash; The Supreme Court took up a deceptively simple question in a case brought by breast cancer patients and medical researchers: Are human genes patentable?
    WASHINGTON — The Supreme Court took up a deceptively simple question in a case brought by breast cancer patients and medical researchers: Are human genes patentable? The answer appeared to be "no" during Monday's oral arguments. The justices...

    Tags: Medical Specialization, University of California, Los Angeles, Pharmaceuticals, Biotechnology Industry, Justice System

    10. Apr 15, 2013 |Story| Los Angeles Times

  10. Supreme Court to consider validity of patents on genes

    WASHINGTON -- The Supreme Court will hear an appeal Monday from breast cancer patients and medical researchers who say the U.S. Patent and Trademark Office made a mistake when it granted a Utah company an exclusive right to profit from testing genes that signal a high risk of cancer.
    WASHINGTON -- The Supreme Court will hear an appeal Monday from breast cancer patients and medical researchers who say the U.S. Patent and Trademark Office made a mistake when it granted a Utah company an exclusive right to profit from testing genes...

    Tags: Medical Specialization, American Civil Liberties Union, Biotechnology Industry, Justice System, Invention and Innovation

    11. Apr 15, 2013 |Story| Los Angeles Times

  11. Supreme Court considers gene patents; scientists react

    As the U.S. Supreme Court heard oral arguments in the case against Myriad Genetics, scientists who are skeptical of the idea of patenting genes said they were hopeful that the justices would overturn the Utah company's claims.
    As the U.S. Supreme Court heard oral arguments in the case against Myriad Genetics, scientists who are skeptical of the idea of patenting genes said they were hopeful that the justices would overturn the Utah company's claims. "I was on pins and needles...

    Tags: Medical Specialization, Biotechnology Industry, U.S. Supreme Court, Ronald Reagan UCLA Medical Center, Science and Technology

    12. Apr 15, 2013 |Story| Los Angeles Times

  12. Why genetic patents are good for patients [Blowback]

    <span class="toolSet" style="width: 335px;"><span class="byline">In their April 12 Op-Ed article "<a href="http://www.latimes.com/news/opinion/commentary/la-oe-darnovsky-breast-genes-patents-20130412,0,2847752.story">Who should own DNA? All of us</a>," Marcy Darnovsky and Karuna Jaggar write about Myriad's patents on BRCA1 and BRCA2, the so-called breast cancer genes (which were under review Monday at the U.S. Supreme Court), as if they have served little purpose in the development of tests that have helped more than 1 million women to understand their risks of breast cancer and ovarian cancer.</span></span>
    In their April 12 Op-Ed article "Who should own DNA? All of us," Marcy Darnovsky and Karuna Jaggar write about Myriad's patents on BRCA1 and BRCA2, the so-called breast cancer genes (which were under review Monday at the U.S. Supreme Court), as if they...

    Tags: Biotechnology Industry, U.S. Supreme Court, Medical Research, Science and Technology, Patents, Copyrights and Trademarks

 1  2 • Next >
Original site for Myriad Genetics Incorporated topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Myriad Genetics Incorporated Photos
On Thursday, a federal appeals court found that Myriad...
(August 17, 2012)
dna helix
A woman gets a mammogram to screen for breast cancer. A...
(July 25, 2012)
Woman getting mammogram